Skip to main content
  • FDA Approves Symplicity Spyral RDN Device to Treat Hypertension

    The Symplicity Spyral Renal Denervation System received marketing approval from the U.S. Food and Drug Administration (FDA) to treat hypertension, Medtronic announced Friday.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details